Department of Neurology, Cedars-Sinai Medical Center

Los Angeles, California 90048

0 studies enrolling now · 2 studies all time

What they study most

Charcot-Marie-Tooth Disease Type 1A, Charcot-Marie-Tooth Disease, Type IA

Studies at this site

• Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A — Status unconfirmed
• Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT) — Completed